Are Investors Undervaluing NCS Multistage (NCSM) Right Now? — Positive
NCSM Zacks Investment Research — August 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Kingstone Companies (KINS) Right Now? — Positive
KINS Zacks Investment Research — August 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in XPLR Infrastructure, LP (f/k/a NextEra Energy Partners, LP) of Class Action Lawsuit and Upcoming Deadlines - XIFR — Neutral
XIFR GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against XPLR Infrastructure, LP (“XPLR” or the “Company”) (NYSE: XIFR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT — Neutral
SRPT GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR — Neutral
CAPR GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
CMS Energy Set to Benefit From Renewable Growth & Capital Deployment — Positive
CMS Zacks Investment Research — August 25, 2025CMS plans $20 billion in capital investments and major renewable expansion while retiring coal units by 2025.
Angi (ANGI) Just Flashed Golden Cross Signal: Do You Buy? — Positive
ANGI Zacks Investment Research — August 25, 2025From a technical perspective, Angi (ANGI) is looking like an interesting pick, as it just reached a key level of support. ANGI recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Generac Holdings (GNRC) Just Reclaimed the 20-Day Moving Average — Positive
GNRC Zacks Investment Research — August 25, 2025From a technical perspective, Generac Holdings (GNRC) is looking like an interesting pick, as it just reached a key level of support. GNRC recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
YMAX Vs. YMAG: Both Offer High Yield Income Weekly, Both Are Very High-Risk Investments — Neutral
YMAG Seeking Alpha — August 25, 2025I focus on high-yield, income-generating ETFs and CEFs for retirement, accepting higher risk for greater passive income and compounding. YieldMax Magnificent 7 Fund of Option Income ETFs and YieldMax Universe Fund of Option Income ETFs are high-risk, high-reward ETFs offering weekly distributions and total returns exceeding 25% over the past year. YMAG is more concentrated in Magnificent 7 stocks, while YMAX offers broader diversification, including alternative assets and more holdings.
Pomerantz Law Firm Announces the Filing of a Class Action Against Tesla, Inc. and Certain Officers – TSLA — Neutral
TSLA GlobeNewsWire — August 25, 2025NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA) and certain officers. The class action, filed in the United States District Court for the Western District of Texas, and docketed under 25-cv-01213, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Tesla securities between April 19, 2023 and June 22, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws …
CNBC's Jim Cramer discusses his thoughts on this enterprise software company.
Here's Why Investors Should Bet on LATAM Airlines Stock for Now — Positive
LTM Zacks Investment Research — August 25, 2025LTM soars with strong demand, 84.5% stock improvement, fleet upgrades and premium service enhancements fueling growth momentum.
Karooooo Ltd. (KARO) Crossed Above the 50-Day Moving Average: What That Means for Investors — Positive
KARO Zacks Investment Research — August 25, 2025Karooooo Ltd. (KARO) reached a significant support level, and could be a good pick for investors from a technical perspective.
Brokers Suggest Investing in New Gold (NGD): Read This Before Placing a Bet — Neutral
NGD Zacks Investment Research — August 25, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Is It Worth Investing in Zscaler (ZS) Based on Wall Street's Bullish Views? — Positive
ZS Zacks Investment Research — August 25, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term — Positive
HCA Zacks Investment Research — August 25, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Disney (DIS) Is Considered a Good Investment by Brokers: Is That True? — Neutral
DIS Zacks Investment Research — August 25, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Earnings Growth & Price Strength Make Lam Research (LRCX) a Stock to Watch — Positive
LRCX Zacks Investment Research — August 25, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Superior Group (SGC) Just Overtook the 200-Day Moving Average — Positive
SGC Zacks Investment Research — August 25, 2025From a technical perspective, Superior Group (SGC) is looking like an interesting pick, as it just reached a key level of support. SGC recently overtook the 200-day moving average, and this suggests a long-term bullish trend.
Wall Street Analysts Think Roblox (RBLX) Is a Good Investment: Is It? — Positive
RBLX Zacks Investment Research — August 25, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?